scholarly article | Q13442814 |
P2093 | author name string | P. Gruss | |
S. Oroszlan | |||
E. M. Scolnick | |||
M. O. Weeks | |||
T. Y. Shih | |||
R. Dhar | |||
P2860 | cites work | The protein encoded by the transforming gene of avian sarcoma virus (pp60src) and a homologous protein in normal cells (pp60proto-src) are associated with the plasma membrane | Q28575831 |
Functional organization of the Harvey murine sarcoma virus genome | Q33921853 | ||
Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses | Q34032926 | ||
Mapping of transforming region of the Harvey murine sarcoma virus genome by using insertion-deletion mutants constructed in vitro | Q36402068 | ||
p21 of Kirsten murine sarcoma virus is thermolabile in a viral mutant temperature sensitive for the maintenance of transformation | Q36501127 | ||
Markedly elevated levels of an endogenous sarc protein in a hemopoietic precursor cell line | Q36956402 | ||
The Assembly of Proteins into Biological Membranes: The Membrane Trigger Hypothesis | Q38000320 | ||
15 Cleavage at aspartylprolyl bonds | Q39173043 | ||
Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus | Q40241805 | ||
In vivo chemical modification of proteins (post-translational modification). | Q40261687 | ||
Transfer of proteins across membranes | Q40313007 | ||
Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus | Q45105517 | ||
SV40 recombinant molecules express the gene encoding p21 transforming protein of Harvey murine sarcoma virus | Q45801051 | ||
Identification of a normal vertebrate cell protein related to the p21 src of harvey murine sarcoma virus | Q45802956 | ||
The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes | Q53570306 | ||
Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry | Q53577737 | ||
Isolation of adenylate cyclase-enriched membranes from mammalian cells using concanavalin A | Q55491286 | ||
Biosynthesis and processing of cellular and viral polyproteins | Q72869705 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microbiology | Q7193 |
immunology | Q101929 | ||
Harvey murine sarcoma virus | Q18976291 | ||
P304 | page(s) | 253-261 | |
P577 | publication date | 1982-04-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Identification of a precursor in the biosynthesis of the p21 transforming protein of harvey murine sarcoma virus | |
P478 | volume | 42 |
Q41091755 | A carboxyl-terminal cysteine residue is required for palmitic acid binding and biological activity of the ras-related yeast YPT1 protein. |
Q41331407 | A novel yeast mutant defective in the processing of ras proteins: assessment of the effect of the mutation on processing steps |
Q36919306 | Acylation of the 176R (19-kilodalton) early region 1B protein of human adenovirus type 5. |
Q36910269 | Antibodies to the ras gene product inhibit adenylate cyclase and accelerate progesterone-induced cell division in Xenopus laevis oocytes |
Q36952191 | Antibody of predetermined specificity to a carboxy-terminal region of H-ras gene products inhibits their guanine nucleotide-binding function |
Q36217321 | Biosynthesis and interconversion of Drosophila nuclear lamin isoforms during normal growth and in response to heat shock |
Q36926513 | Comparative biochemical properties of p21 ras molecules coded for by viral and cellular ras genes |
Q36901535 | Development and analysis of a transformation-defective mutant of Harvey murine sarcoma tk virus and its gene product. |
Q43183626 | Diacylglycerol production in Xenopus laevis oocytes after microinjection of p21ras proteins is a consequence of activation of phosphatidylcholine metabolism |
Q36908523 | Direct identification of palmitic acid as the lipid attached to p21ras |
Q33929812 | Dynamic fatty acylation of p21N-ras |
Q37672156 | Effects of two major activating lesions on the structure and conformation of human ras oncogene products |
Q54694125 | Expression of chimeric ras protein with OmpF signal peptide in Escherichia coli: localization of OmpF fusion protein in the inner membrane |
Q34245213 | Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins |
Q36909119 | Expression of viral p21ras during acquisition of a transformed phenotype by rat adrenal cortex cells infected with Kirsten murine sarcoma virus |
Q36843110 | Fatty acylation is important but not essential for Saccharomyces cerevisiae RAS function |
Q36781144 | Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum |
Q36849579 | Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells |
Q36841976 | Guanine nucleotide activation of, and competition between, RAS proteins from Saccharomyces cerevisiae |
Q54667913 | Guanine-nucleotide binding activity, interaction with GTPase-activating protein and solution conformation of the human c-Ha-Ras protein catalytic domain are retained upon deletion of C-terminal 18 amino acid residues. |
Q37576661 | Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli. |
Q33940060 | Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus |
Q36919721 | Heterologous expression and characterization of the human R-ras gene product |
Q45117950 | In vitro and in vivo metabolism of the anti-cancer agent CI-1040, a MEK inhibitor, in rat, monkey, and human |
Q45796896 | Incorporation of lipids into variants of Moloney sarcoma virus which produce gag-mos fusion proteins |
Q36792845 | Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. |
Q24555646 | Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080 |
Q36946976 | Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs |
Q33589256 | Modification of nuclear lamin proteins by a mevalonic acid derivative occurs in reticulocyte lysates and requires the cysteine residue of the C-terminal CXXM motif |
Q40178462 | Molecular lesions in cancer |
Q37564140 | Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas |
Q36976043 | Mouse Cells Contain Two Distinct ras Gene mRNA Species That Can Be Translated into a p21 onc Protein |
Q36917694 | Mutational analysis of a ras catalytic domain |
Q45799818 | Nucleotide Sequence of the p21 Transforming Protein of Harvey Murine Sarcoma Virus |
Q35276992 | Nucleotide sequence of tworasHrelated-genes isolated from the yeastSaccharomyces cerevisiae |
Q40109316 | Onc genes and other new targets for cancer chemotherapy |
Q40179507 | Oncogenes and Cancer: The p21rasGenes |
Q36915056 | Photoaffinity labeling with GTP of viral p21 ras protein expressed in Escherichia coli |
Q33562770 | Post-translational processing of p21ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis |
Q36853371 | Posttranslational processing of p21 ras proteins involves palmitylation of the C-terminal tetrapeptide containing cysteine-186 |
Q27936070 | Processing and fatty acid acylation of RAS1 and RAS2 proteins in Saccharomyces cerevisiae |
Q36888692 | Purification and characterization of human H-ras proteins expressed in Escherichia coli |
Q24631695 | Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method |
Q33892360 | Ras activity regulates cyclin E degradation by the Fbw7 pathway. |
Q29615405 | Ras oncogenes: split personalities |
Q36884242 | Regulation of a ras-related protein during development of Dictyostelium discoideum |
Q36923580 | The int-1 proto-oncogene products are glycoproteins that appear to enter the secretory pathway |
Q38282553 | The ras oncogene--an important regulatory element in lower eucaryotic organisms. |
Q45798971 | The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid |
Q33880500 | The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR. |
Q33931877 | Transforming p21 ras protein: flexibility in the major variable region linking the catalytic and membrane-anchoring domains. |
Q67258587 | Yeast RAS2 affects cell viability, mitotic division and transient gene expression in Nicotiana species |